We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.57%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.52B
AUM Growth
+$35M
Cap. Flow
+$831M
Cap. Flow %
23.65%
Top 10 Hldgs %
38.14%
Holding
2,292
New
549
Increased
398
Reduced
416
Closed
501
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PASG icon
1451
Passage Bio
PASG
$14.7M
$59K ﹤0.01%
1,257
+527
+72% +$24.6K
TAST
1452
DELISTED
Carrols Restaurant Group, Inc.
TAST
$57K ﹤0.01%
27,992
EVC icon
1453
Entravision Communication
EVC
$1.04B
$55K ﹤0.01%
+12,057
New +$61.9K
IRON icon
1454
Disc Medicine
IRON
$2.99B
$53K ﹤0.01%
1,037
-2
-0.2% -$88
KPTI icon
1455
Karyopharm Therapeutics
KPTI
$44.6M
$53K ﹤0.01%
+786
New +$72.1K
SY
1456
So-Young International
SY
$228M
$53K ﹤0.01%
62,219
+23,855
+62% +$29.9K
OSI.WS
1457
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
$53K ﹤0.01%
275,000
OPAD icon
1458
Offerpad Solutions
OPAD
$23.4M
$52K ﹤0.01%
160
+11
+7% +$7.38K
LEV
1459
DELISTED
The Lion Electric Company
LEV
$52K ﹤0.01%
+12,357
New +$72.5K
CVIIW
1460
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$52K ﹤0.01%
150,000
SDC
1461
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$52K ﹤0.01%
50,000
ACHV icon
1462
Achieve Life Sciences
ACHV
$685M
$49K ﹤0.01%
+10,108
New +$68.6K
NFYS.WS
1463
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
$49K ﹤0.01%
306,250
MKFG
1464
DELISTED
Markforged Holding Corporation
MKFG
$48K ﹤0.01%
2,574
-359
-12% -$10.5K
JUGGW
1465
DELISTED
Jaws Juggernaut Acquisition Corporation Warrant
JUGGW
$48K ﹤0.01%
130,225
PRVB
1466
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$48K ﹤0.01%
+12,064
New +$57.2K
JRSH icon
1467
Jerash Holdings
JRSH
$62.5M
$47K ﹤0.01%
10,035
-21,253
-68% -$127K
ZVIA icon
1468
Zevia
ZVIA
$108M
$47K ﹤0.01%
+16,723
New +$51.8K
WEAV icon
1469
Weave Communications
WEAV
$434M
$46K ﹤0.01%
+15,165
New +$72.9K
BCAB icon
1470
BioAtla
BCAB
$5.74M
$45K ﹤0.01%
+316
New +$50.3K
HYFM icon
1471
Hydrofarm Holdings
HYFM
$8.77M
$44K ﹤0.01%
+1,253
New +$102K
RIOT icon
1472
CALL
Riot Platforms
RIOT
$7.32B
$44K ﹤0.01%
10,600
-100
-0.9% -$928
SPKAR
1473
DELISTED
SPK Acquisition Corp. Right
SPKAR
$44K ﹤0.01%
200,000
IQ icon
1474
PUT
iQIYI
IQ
$1.33B
$42K ﹤0.01%
+10,000
New +$40.2K
TYGOW
1475
DELISTED
Tigo Energy, Inc. Warrant
TYGOW
$42K ﹤0.01%
200,000

Similar funds

Prelude Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Prelude Capital Management held 2,292 positions worth $3.52B, up 1% from $3.48B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Prelude Capital Management deployed $831M of net new capital in Q2 2022, opening 549 new positions and adding to 398 existing holdings. Its largest new stake was SM Energy: 2,001,257 shares worth $1.94M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was TSMC, an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q2 2022 buy was SM Energy: 2,001,257 shares worth $1.94M.
  • Prelude Capital Management added most to Lockheed Martin in Q2 2022, an estimated $85.8M increase.
  • Prelude Capital Management's biggest Q2 2022 reduction was TSMC, cutting an estimated $13.2M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q2 2022, selling an estimated $42M.
  • Prelude Capital Management's ten largest holdings make up 38% of its $3.52B portfolio in Q2 2022.
  • Prelude Capital Management opened 549 new positions and closed 501 in Q2 2022.
  • Prelude Capital Management's portfolio value rose 1% quarter-over-quarter to $3.52B.

Based on Prelude Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.